S&P 500   4,519.63 (+0.74%)
DOW   35,457.31 (+0.56%)
QQQ   375.47 (+0.76%)
AAPL   148.76 (+1.51%)
MSFT   308.23 (+0.31%)
FB   339.99 (+1.39%)
GOOGL   2,864.74 (+0.32%)
TSLA   864.27 (-0.67%)
AMZN   3,444.15 (-0.08%)
NVDA   222.90 (+0.31%)
BABA   177.00 (+6.10%)
NIO   40.03 (+1.06%)
CGC   14.34 (+8.64%)
GE   104.73 (+0.59%)
AMD   116.33 (-0.09%)
MU   67.57 (+0.46%)
T   25.59 (+1.03%)
F   15.42 (-0.90%)
ACB   7.45 (+7.66%)
DIS   171.18 (+0.02%)
PFE   42.09 (+1.86%)
BA   215.97 (-0.47%)
AMC   40.80 (-5.18%)
S&P 500   4,519.63 (+0.74%)
DOW   35,457.31 (+0.56%)
QQQ   375.47 (+0.76%)
AAPL   148.76 (+1.51%)
MSFT   308.23 (+0.31%)
FB   339.99 (+1.39%)
GOOGL   2,864.74 (+0.32%)
TSLA   864.27 (-0.67%)
AMZN   3,444.15 (-0.08%)
NVDA   222.90 (+0.31%)
BABA   177.00 (+6.10%)
NIO   40.03 (+1.06%)
CGC   14.34 (+8.64%)
GE   104.73 (+0.59%)
AMD   116.33 (-0.09%)
MU   67.57 (+0.46%)
T   25.59 (+1.03%)
F   15.42 (-0.90%)
ACB   7.45 (+7.66%)
DIS   171.18 (+0.02%)
PFE   42.09 (+1.86%)
BA   215.97 (-0.47%)
AMC   40.80 (-5.18%)
S&P 500   4,519.63 (+0.74%)
DOW   35,457.31 (+0.56%)
QQQ   375.47 (+0.76%)
AAPL   148.76 (+1.51%)
MSFT   308.23 (+0.31%)
FB   339.99 (+1.39%)
GOOGL   2,864.74 (+0.32%)
TSLA   864.27 (-0.67%)
AMZN   3,444.15 (-0.08%)
NVDA   222.90 (+0.31%)
BABA   177.00 (+6.10%)
NIO   40.03 (+1.06%)
CGC   14.34 (+8.64%)
GE   104.73 (+0.59%)
AMD   116.33 (-0.09%)
MU   67.57 (+0.46%)
T   25.59 (+1.03%)
F   15.42 (-0.90%)
ACB   7.45 (+7.66%)
DIS   171.18 (+0.02%)
PFE   42.09 (+1.86%)
BA   215.97 (-0.47%)
AMC   40.80 (-5.18%)
S&P 500   4,519.63 (+0.74%)
DOW   35,457.31 (+0.56%)
QQQ   375.47 (+0.76%)
AAPL   148.76 (+1.51%)
MSFT   308.23 (+0.31%)
FB   339.99 (+1.39%)
GOOGL   2,864.74 (+0.32%)
TSLA   864.27 (-0.67%)
AMZN   3,444.15 (-0.08%)
NVDA   222.90 (+0.31%)
BABA   177.00 (+6.10%)
NIO   40.03 (+1.06%)
CGC   14.34 (+8.64%)
GE   104.73 (+0.59%)
AMD   116.33 (-0.09%)
MU   67.57 (+0.46%)
T   25.59 (+1.03%)
F   15.42 (-0.90%)
ACB   7.45 (+7.66%)
DIS   171.18 (+0.02%)
PFE   42.09 (+1.86%)
BA   215.97 (-0.47%)
AMC   40.80 (-5.18%)
ASX:HLA

Healthia Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume155,400 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend Yield3.53%
BetaN/A

Receive HLA News and Ratings via Email

Sign-up to receive the latest news and ratings for Healthia and its competitors with MarketBeat's FREE daily newsletter.


About Healthia

Healthia Limited provides health services in Australia. The company operates 72 podiatry clinics under the My FootDr brand; 23 physiotherapy clinics under the Allsports Physiotherapy brand; and 7 hand therapy clinics under the Extend Rehabilitation brand, as well as manufactures and sells 3D printed orthotic devices for podiatry clinics. It also sells podiatry and foot and nail care products, podiatry equipment, surgical instruments, orthotic materials, clinical consumables to podiatrists, hospitals, medical centres, nursing homes, and allied health professionals. The company was incorporated in 2018 and is based in Bowen Hills, Australia.

Headlines

No headlines for this company have been tracked by MarketBeat.com

Industry, Sector and Symbol

Industry
Medical Care Facilities
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Employees
N/A
Year Founded
N/A

Sales & Book Value

Annual Sales
$136.95 million
Book Value
A$0.85 per share

Profitability

Debt

Price-To-Earnings

Miscellaneous

Next Earnings Date
N/A
Optionable
Not Optionable

MarketRank

Overall MarketRank

1.33 out of 5 stars

Analyst Opinion: 0.0Community Rank: 5.0Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -












Healthia (ASX:HLA) Frequently Asked Questions

What stocks does MarketBeat like better than Healthia?

Wall Street analysts have given Healthia a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Healthia wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How often does Healthia pay dividends? What is the dividend yield for Healthia?

Healthia declared a Final dividend on Tuesday, August 31st. Investors of record on Tuesday, October 26th will be given a dividend of 0.025 per share on Tuesday, October 26th. This represents a yield of 1.25%. The ex-dividend date of this dividend is Monday, September 6th. This is a positive change from Healthia's previous Final dividend of A$0.02.
View Healthia's dividend history
.

Is Healthia a good dividend stock?

Healthia pays an annual dividend of A$0.06 per share and currently has a dividend yield of 3.53%. The dividend payout ratio of Healthia is 96.77%. Payout ratios above 75% are not desirable because they may not be sustainable.
View Healthia's dividend history.

Who are Healthia's key executives?

Healthia's management team includes the following people:
  • Mr. Wesley James Coote, Group MD, CEO & Director
  • Mr. Christopher Banks, Group Chief Financial Officer
  • Ms. Lisa Roach, Group Chief People Officer
  • Mr. Darren Lindsey Stewart, Director of Podiatry & Exec. Director
  • Mr. Anthony Peter Ganter, Group Chief Bus. Devel. & Strategy Officer and Exec. Director
  • Mr. Dean Hartley, CEO of Bodies, Minds, Feet & Ankle
  • Ms. Katherine Baker, Group Chief Operating Officer
  • Ms. Leeann Ellison, Group Chief Marketing Officer
  • Dr. Kerrie Evans, Group Chief Education & Research Officer
  • Mr. Colin Jonathan Kangisser, CEO of Eyes & Ears and Director

What is Healthia's stock symbol?

Healthia trades on the ASX under the ticker symbol "HLA."

How much money does Healthia make?

Healthia has a market capitalization of $0.00 and generates $136.95 million in revenue each year.

What is Healthia's official website?

The official website for Healthia is www.healthia.com.au.

How can I contact Healthia?

The company can be reached via phone at 61 7 3180 4900.


This page was last updated on 10/19/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.